100 episodes
Keeping Current CME Medscape
-
- Health & Fitness
Hear from experts as they discuss timely clinical topics as well as relevant and actionable strategies for practice improvement. This podcast is available for CME credit.
-
Evolution of the Care of Patients With Advanced Ovarian Cancer
Do you know the best way to manage your patients with newly diagnosed advanced ovarian cancer?
Credit available for this activity expires: 4/23/25
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000702?ecd=bdc_podcast_libsyn_mscpedu -
Axial Spondyloarthritis Treatment Advancements: Where Do Janus Kinase Inhibitors Fit In?
Join our expert panel as they discuss the role of Janus kinase (JAK) inhibitors in the treatment of axial spondyloarthritis (axSpA).
Credit available for this activity expires: 4/24/25
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000707?ecd=bdc_podcast_libsyn_mscpedu -
Knowing How and When to Switch Medications in Schizophrenia
Which patients with schizophrenia might benefit from switching medications, and what should we consider when initiating the switch?
Credit available for this activity expires: 4/24/25
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000709?ecd=bdc_podcast_libsyn_mscpedu -
For Pharmacists: Evolution of HER2-Targeted Therapy in Gastroesophageal Adenocarcinoma
Did you know that HER2-targeted therapy is an established treatment option for patients with HER2-positive metastatic gastric/gastroesophageal junction (GEJ) cancer?
Credit available for this activity expires: 4/16/25
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000688?ecd=bdc_podcast_libsyn_mscpedu -
Care Pathways for Diagnostic Excellence: Understanding Provider Roles and Responsibilities
Who in the care team can detect cognitive impairment and aid in diagnosing early stages of Alzheimer's disease (AD)?
Credit available for this activity expires: 4/10/25
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000668?ecd=bdc_podcast_libsyn_mscpedu -
Evolution of HER2-Targeted Therapy in Gastroesophageal Adenocarcinoma
Did you know that HER2-targeted therapy is an established treatment option for patients with HER2-positive metastatic gastric/gastroesophageal junction (GEJ) cancer?
Credit available for this activity expires: 3/29/25
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000593?ecd=bdc_podcast_libsyn_mscpedu